Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: The Eastern Cooperative Oncology Group (ECOG) results of protocol E1293
Avi I. Einzig*, Donna Neuberg, Scot C. Remick, Daniel D. Karp, Peter J. O'Dwyer, James A. Stewart, Al B. Benson
Dive into the research topics of 'Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: The Eastern Cooperative Oncology Group (ECOG) results of protocol E1293'. Together they form a unique fingerprint.